OVERVIEW BECAUSE ACCESS IS EVERYTHING Even the most sophisticated, cutting-edge medical diagnostics aren’t of value unless we can get them to those who need them most. At Access Bio, we believe every life is precious, and every human on earth deserves the opportunity to live a healthy life, free from the threat of infectious diseases. Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. Based on the greatest needs and the potential to do the most good, we work with partners across the world, including the Bill and Melinda Gates Foundation, the World Health Organization, UNICEF, and many others. VISION OUR VISION AND STRATEGY A Sustainable Business Based on Innovation, Value, and Global Good Heading Global pioneer in invitro diagnostic technologies Promote health and well-being of mankind via accurate diagnosis of diseases REINFORCE MARKET PRESENCE AND DIVERSIFY MARKETS Reinforce market footing in malaria diagnosis; launch new diagnostic products including tests for COVID-19, G6PD deficiency, dengue fever, influenza, and strep STRENGTHEN QUALITY CONTROL AND CUSTOMER RELATIONSHIPS Maintain stringent quality control; strengthen relationships with customers including international agencies, non-profit organizations, and retailers. DEVELOP VALUE-ADDED PRODUCTS Build a portfolio of value-added products based on cutting-edge technologies in in vitro diagnostics. ENHANCE SUSTAINABILITY OF PROFITS Reduce costs via product diversification, economies of scale, and production automation. CEO MESSAGE EACH AND EVERY LIFE IS PRECIOUS A healthy life, free of illness, is a long-held wish in society. Guided by the basic principles of cherishing life and health for all people, Access Bio has been dedicated to the research, development and quality improvement of the medical diagnosis industry. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized products of outstanding quality to battle malaria and other diseases that pose a serious health threat across the globe. Since our inception in 2002, we have built a strong presence in the global market for the diagnostic testing of malaria and instilled hope for a healthy life among those suffering from this deadly disease. Our Work Has Just Begun As we look toward the future, Access Bio will not merely respond to the changing environment, but move forward with a proactive stance. With efficient processes and a dynamic culture, we will harness our competitive advantage to develop next-generation technologies and sustain growth. As a world leader in medical diagnosis, Access Bio is committed in promoting hope for a healthy life and garnering the trust of all stakeholders. Thank you. 65 Clyde Rd. Suite A Somerset, NJ 08873 USA +1. 732.873.4040 E-mail : info@accessbio.net ABOUT US Overview Vision CEO Message Global Operations PRODUCTS Product List Covid-19 Tests Rapid Diagnostic Tests Analyzers Molecular Diagnostics NEWS News and Events CAREERS Open Positions INVESTORS Investors Relations Korean Investors LEGAL Privacy Policy Terms & Conditions The information, software, products, and services included in or available through the site may include inaccuracies or typographical errors. Changes are periodically added to the information herein. Access bio and/or its suppliers may make improvements and/or changes in the site at any time. Access bio and/or its suppliers make no representations about the suitability, reliability, availability, timeliness, and accuracy of the information, software, products, services and related graphics contained on the site for any purpose. To the maximum extent permitted by applicable law, all such information, software, products, services, and related graphics are provided “as is” without warranty or condition of any kind. © 2021 ACCESS BIO. ALL RIGHTS RESERVED. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Cookie Settings Accept All